Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
61.82
-1.33 (-2.11%)
At close: Jul 17, 2026, 4:00 PM EDT
61.70
-0.12 (-0.19%)
After-hours: Jul 17, 2026, 6:35 PM EDT
Moderna Employees
Moderna had 4,700 employees as of December 31, 2025. The number of employees decreased by 1,100 or -18.97% compared to the previous year.
Employees
4,700
Change (1Y)
-1,100
Growth (1Y)
-18.97%
Revenue / Employee
$473,404
Profits / Employee
-$679,574
Market Cap
24.53B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4,700 | -1,100 | -18.97% |
| Dec 31, 2024 | 5,800 | 200 | 3.57% |
| Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
| Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
| Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
| Dec 31, 2020 | 1,300 | 470 | 56.63% |
| Dec 31, 2019 | 830 | 70 | 9.21% |
| Dec 31, 2018 | 760 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Genmab | 3,088 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Insmed | 1,664 |
| Ascendis Pharma | 1,189 |
| Revolution Medicines | 883 |
MRNA News
- 1 day ago - Moderna announces first participant dosed in Phase 1 trial of mRNA-4200 - TheFly
- 1 day ago - Arbutus Biopharma receives $178M settlement agreement from Moderna - TheFly
- 1 day ago - Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors - Accesswire
- 7 days ago - Here’s Why Moderna Stock (MRNA) Is Crashing Today — July 10, 2026 - TipRanks
- 7 days ago - Moderna falls -10.7% - TheFly
- 7 days ago - Moderna falls -8.2% - TheFly
- 8 days ago - Moderna wins EU contract for RSV vaccine supply - Reuters
- 8 days ago - Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026 - Accesswire